Progress in Clinical Research on Gonadotropin-Releasing Hormone Receptor Antagonists for the Treatment of Prostate Cancer

Gonadotropin-releasing hormone (GnRH) receptor agonists are still the most commonly used androgen deprivation treatment (ADT) drugs for prostate cancer in clinical practice. Currently, the GnRH receptor antagonists used for endocrine therapy for prostate cancer primarily include degarelix and relugo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yi-Fu, Fu, Sheng-Qiang, Yan, Yu-Chang, Gong, Bin-Bin, Xie, Wen-Jie, Yang, Xiao-Rong, Sun, Ting, Ma, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896730/
https://www.ncbi.nlm.nih.gov/pubmed/33623372
http://dx.doi.org/10.2147/DDDT.S291369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896730/
https://www.ncbi.nlm.nih.gov/pubmed/33623372
http://dx.doi.org/10.2147/DDDT.S291369

Ejemplares similares